Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bone Medical
West Perth, Western Australia, Australiabone-ltd.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Bone Medical was an Australian biopharmaceutical company focused on therapies for bone and joint diseases, particularly osteoporosis and osteoarthritis. The company was listed on the ASX under the ticker BNE and advanced an oral calcitonin product known as Capsitonin for osteoporosis, positioning it as a reformulation and development-stage asset. Historical company materials describe a pipeline centered on bone disease rather than a broad multi-platform technology base. Bone Medical later changed its corporate name to Botanix Pharmaceuticals, so the Bone Medical identity is no longer an active standalone operating company.
- Therapeutic areas
- EndocrinologyRheumatology
- Modalities
- PeptidesSmall molecule
- Industry
- Biotech
Beyond the preview
Go deeper on Bone Medical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bone Medical.